Clinical Laserthermia Systems AB (publ) (STO:CLS.B)
Sweden · Delayed Price · Currency is SEK 1.930
-0.050 (-2.53%)
Jul 24, 2026, 5:29 PM CET
STO:CLS.B Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11.57 | 23.61 | 18.5 | 10.29 | 4.91 | 2.41 | |
Revenue Growth (YoY) | -55.42% | 27.61% | 79.77% | 109.78% | 103.91% | -5.79% |
Cost of Revenue | 10.9 | 12.31 | 7.56 | 6.56 | 6.4 | 5.88 |
Gross Profit | 0.67 | 11.3 | 10.95 | 3.73 | -1.49 | -3.47 |
Selling, General & Admin | 38.9 | 37.33 | 62.04 | 66.13 | 62.29 | 54.2 |
Depreciation & Amortization Expenses | 2.65 | 2.58 | 2.67 | 2.71 | 2.45 | 2.79 |
Other Operating Expenses | 0.33 | 0.19 | 0.49 | 0.83 | 1.21 | 0.23 |
Total Operating Expenses | 41.88 | 40.11 | 65.2 | 69.67 | 65.95 | 57.21 |
Operating Income | -41.21 | -28.81 | -54.25 | -65.93 | -67.44 | -60.68 |
Interest Income | 1.39 | -13.14 | 6.83 | -5.18 | 7.15 | 2.95 |
Interest Expense | -0.11 | -0.09 | -0.43 | -9.76 | -10.97 | -6.41 |
Total Non-Operating Income (Expense) | 1.29 | -13.24 | 6.39 | -14.94 | -3.82 | -3.46 |
Pretax Income | -39.92 | -42.05 | -47.86 | -80.88 | -71.27 | -64.14 |
Net Income | -39.92 | -42.05 | -47.86 | -80.88 | -71.27 | -64.14 |
Minority Interest in Earnings | -0.44 | -0.43 | -0.24 | 1.08 | 0.61 | 0.53 |
Net Income to Common | -39.49 | -41.61 | -47.62 | -81.96 | -70.66 | -63.62 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 30 | 26 | 26 | 83 | 83 | 0 |
Shares Outstanding (Diluted) | 30 | 31 | 26 | 83 | 83 | 0 |
Shares Change (YoY) | 57.04% | 20.47% | -68.98% | - | 28903.55% | 30.24% |
EPS (Basic) | -1.30 | -1.63 | -4.35 | -0.12 | -0.85 | -224.00 |
EPS (Diluted) | -1.30 | -1.63 | -4.35 | -0.12 | -0.85 | -224.00 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -32.35 | -35.91 | -63.93 | -68.6 | -82.1 | -66.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.09 | -1.15 | -2.47 | -0.82 | -0.98 | -230.61 |
Gross Margin | 5.76% | 47.84% | 59.16% | 36.27% | -30.43% | -144.18% |
Operating Margin | -356.14% | -122.02% | -293.23% | -640.62% | -1374.68% | -2522.11% |
Profit Margin | -345.03% | -178.09% | -258.67% | -785.81% | -1452.61% | -2665.88% |
FCF Margin | -279.55% | -152.08% | -345.50% | -666.52% | -1673.38% | -2756.48% |
EBITDA | -41.21 | -28.81 | -54.25 | -65.93 | -67.44 | -60.68 |
EBIT | -41.21 | -28.81 | -54.25 | -65.93 | -67.44 | -60.68 |
EBIT Margin | -356.14% | -122.02% | -293.23% | -640.62% | -1374.68% | -2522.11% |